Well Tolerated

Related by string. * w ell . Weller . Welling . wells . WELL . WELLS : Chris Beanie Wells . well oiled machine . Wells Fargo NYSE WFC . SECRETARY CLINTON Well . INDIAN WELLS Calif. . wells drilled / Tolerating . TOLERATED . tolerated . tolerating : tolerated dose MTD . maximally tolerated lipid lowering . tolerating dissent . tolerating homosexuality . tolerating bigotry * Is Well Tolerated *

Related by context. All words. (Click for frequent words.) 82 Previously Treated 81 Monotherapy 81 Phase IIb Trial 81 Antitumor Activity 81 Meets Primary Endpoint 81 Improves Survival 81 Clinical Trial Results 80 Preclinical Data 80 Statistically Significant 80 Investigational Compound 80 Drug Candidate 80 Elderly Patients 79 Survival Benefit 79 Patients Treated 79 Phase 2b Clinical Trial 79 Phase III Clinical Trial 79 Long Term Efficacy 79 Single Dose 79 Combination Treatment 79 Phase III Trial 78 Phase III Trials 78 Phase 2b Trial 78 Efficacious 78 Phase 2b Study 78 Advanced Melanoma 78 Oral Fingolimod 78 II Clinical Trial 78 Improve Survival 78 Is Well Tolerated 78 Statin Therapy 78 Study Evaluating 78 Unfractionated Heparin 78 Adjunctive Therapy 78 Cardiovascular Events 78 Anti Tumor Activity 77 Appears Safe 77 Improved Survival 77 Prolongs Survival 77 Adjuvant Therapy 77 Inhaled Corticosteroids 77 Pooled Analysis 77 Patients Treated With 77 Controlled Trial 77 Infected Patients 77 Significantly Reduced 77 Study Showed 77 Investigational Agent 77 Novel Oral 77 Improves Outcomes 77 Tolerability 77 Novel Antibiotic 77 Demonstrated Significant 77 Low Dose 77 Advanced Prostate Cancer 77 Chronic Hepatitis C 77 Present Preclinical Data 77 Hypertensive Patients 77 Completes Enrollment 76 Pharmacokinetic Study 76 Metastatic Prostate Cancer 76 Effective Than 76 Newly Diagnosed Multiple Myeloma 76 Metastatic Colorectal Cancer 76 Rheumatoid Arthritis Patients 76 Hepatitis C Patients 76 Controlled Study 76 JAK Inhibitor 76 Patients Receiving 76 Double Blind Placebo 76 Phase IIb Clinical Trial 76 Phase 2a Clinical Trial 76 Metastatic Melanoma 76 Previously Untreated 76 Relapsing Multiple Sclerosis 76 Combination Therapy 76 Severe Sepsis 76 Phase 2a Trial 76 Antiviral Activity 75 Knee Osteoarthritis 75 Postmenopausal Women 75 Clinical Trial Evaluating 75 Increased Mortality 75 Pediatric Patients 75 NDA Submission 75 Disease Progression 75 Randomized Phase 75 Metastatic Renal Cell Carcinoma 75 Demonstrates Positive 75 Relapsed Refractory 75 Receives Orphan Drug Designation 75 Pivotal Phase III 75 Patients Undergoing 75 Colorectal Cancer Patients 75 Presents Preclinical Data 75 Tiotropium 75 Cholesterol Lowering Drug 75 Autologous Stem Cell Transplantation 75 Significantly Improved 75 Pulmonary Arterial Hypertension 75 Diabetic Patients 75 Completes Patient Enrollment 75 Prophylactic Treatment 75 Adjuvant Chemotherapy 75 Diabetic Nephropathy 75 Dose Escalation 75 Patient Enrollment 75 Gout Drug 75 Versus Placebo 74 Renal Cell Carcinoma 74 Advanced Renal Cell 74 Zoledronic Acid 74 Investigational Treatment 74 Epilepsy Drug 74 Demonstrates Potent 74 Tumor Growth 74 Relapsed 74 Prostate Cancer Patients 74 Non Responders 74 Myeloma Patients 74 Treating Chronic 74 Clinical Efficacy 74 Advanced Ovarian Cancer 74 Osteoporosis Drug 74 Kinase Inhibitor 74 Treated Patients 74 Chemoradiation 74 Orally Active 74 Fewer Side Effects 74 Demonstrates Efficacy 74 HER2 Positive Breast Cancer 74 Treatment Naïve 74 Adjuvant Treatment 74 Heart Failure Patients 74 Complicated Skin 74 Patients Suffering 74 Kidney Function 74 Anticancer Activity 74 Androgen Deprivation Therapy 74 Partial Onset Seizures 74 IND Application 74 Fixed Dose 74 Treatment Experienced 74 Overactive Bladder 74 Phase IIa Clinical Trial 74 FDA Approvals 74 Beneficial Effects 74 Soft Tissue Sarcoma 74 Investigational Drug 74 Unresectable 74 Newly Diagnosed 74 Treatment Regimen 74 Relapsed Multiple Myeloma 74 Nucleoside 74 Plus Ribavirin 74 Bare Metal Stents 74 Epoetin Alfa 74 Dose Finding 74 Anti Tumor 74 Hypercholesterolemia 73 Immune Responses 73 Clinical Outcome 73 Randomized Double Blind 73 Placebo Controlled Trial 73 Meta Analysis 73 Transdermal Patch 73 Extended Release 73 Fungal Infections 73 Peginterferon Alfa 2a 73 Myelodysplastic Syndromes 73 Enoxaparin 73 Shows Efficacy 73 Hemodialysis Patients 73 Bortezomib 73 Pivotal Trial 73 Treatment Naive HIV 73 Breast Cancer Recurrence 73 Demonstrates Significant 73 Peginterferon 73 Resistant Hypertension 73 FDA Okays 73 Preclinical Study 73 Receptor Agonist 73 Insulin Glargine 73 Increased Risk 73 Humanized Anti 73 Submits NDA 73 Novel Mechanism 73 Kidney Transplant Patients 73 Gene Variant 73 Mouse Model 73 Pivotal Phase 73 Interferon Beta 73 Hormone Refractory Prostate Cancer 73 Castration Resistant Prostate Cancer 73 Anthracycline 73 Multiple Myeloma Patients 73 Dual Antiplatelet Therapy 73 Recombinant Human 73 Advanced Colorectal Cancer 73 Shows Promising 73 Chronic Hepatitis B 73 Acute Ischemic Stroke 72 Drug Shows Promise 72 Postmenopausal Osteoporosis 72 Radical Prostatectomy 72 Presents Positive 72 Partial Seizures 72 Diabetic Neuropathy 72 Breast Cancer Patients 72 Files IND 72 Refractory Hodgkin Lymphoma 72 Induces 72 Cutaneous T 72 Renal Function 72 Treatment Reduces 72 Gene Mutation 72 Solid Tumors 72 Generic Version 72 Randomized Clinical Trial 72 Effectively Treats 72 Combo Therapy 72 Benign Prostatic Hyperplasia 72 Brain Metastases 72 Treatment Naive Patients 72 Dendritic Cells 72 HDAC Inhibitor 72 Hepatitis C Genotype 72 Therapeutic Potential 72 Drug Combo 72 Trial Evaluating 72 Disease Modifying 72 Neuroprotective Effects 72 Osteoporosis Treatment 72 Radiofrequency Ablation 72 Protease Inhibitor 72 Medoxomil 72 Fracture Risk 72 Pivotal Study 72 Fondaparinux 72 Lung Cancer Patients 72 Tezampanel 72 Chronic Sinusitis 72 Significantly Improves 72 Inhibits 72 Mylan Receives Approval 72 Initiate Clinical Trial 72 Study Demonstrates 72 Platelet Inhibition 72 Schizophrenia Drug 72 Renal Impairment 72 Atypical Antipsychotics 72 Treatment Naive 72 Critically Ill Patients 72 Initiate Phase 72 Antipsychotic 72 Osteoporosis Drugs 72 Novel Compound 72 Significantly Reduces 72 Estrogen Therapy 72 Randomized Double blind 72 Cancer Cells 72 Phospholipase A2 72 Localized Prostate Cancer 72 Migraine Drug 72 Relapsing Remitting Multiple Sclerosis 72 Neoadjuvant Chemotherapy 72 Diabetic Neuropathic Pain 72 Premature Infants 72 Rotavirus Vaccine 72 Lung Cancer Drug 72 Fluorouracil 72 Blood Pressure Drug 72 Dose Escalation Study 72 Slow Progression 71 Tumor Cells 71 Lacosamide 71 Receptor Antagonists 71 Obese Patients 71 Dose Ranging Study 71 Subgroup Analysis 71 Kidney Transplant Recipients 71 TNF Blockers 71 Ischemic Stroke 71 Receptor Antagonist 71 Sustained Efficacy 71 Cyclophosphamide 71 Milestone Payment 71 Liver Injury 71 Hsp# Inhibitor 71 Initiates Phase 71 Replacement Therapy 71 Viral Suppression 71 Liver Metastases 71 Endovascular Treatment 71 Node Positive 71 Beta Blocker 71 Lung Cancer Trial 71 Prospective Randomized 71 PEGylated Fab fragment 71 Universal Flu Vaccine 71 FDA Clears 71 HCV Protease Inhibitor 71 Nebulized 71 Phase 1b Clinical Trial 71 Cocaine Addiction 71 Reduces Risk 71 Commonly Prescribed 71 Proves Effective 71 Initiates Phase III 71 Cholesterol Drugs 71 Treatment Resistant 71 Sapacitabine 71 Nilotinib 71 Gene Variation 71 ACE Inhibitors 71 Arthritis Drug 71 Liver Failure 71 Randomized Controlled Trial 71 Venous Thromboembolism 71 FDA Approves 71 Cognitive Impairment 71 Hormone Receptor Positive 71 Interferon Gamma 71 Seasonal Allergic Rhinitis 71 Epratuzumab 71 Demonstrates Potential 71 Higher Doses 71 PRN FDA Approves 71 Pivotal Trials 71 Endometrial Cancer 71 Granted Orphan Drug 71 Progressive Multifocal Leukoencephalopathy 71 Meet Primary Endpoint 71 Topical Treatment 71 Breast Cancers 71 Randomized Double Blind Placebo 71 Immunogenic 71 Stent Implantation 71 Premenopausal Women 71 Advanced Pancreatic Cancer 71 Therapy Improves 71 Chronic Myeloid Leukemia 71 Pharmacodynamics 71 Clinically Proven 71 Improve Outcomes 71 Potentially Fatal 71 Treatment Naïve Patients 71 Spectrum Pharmaceuticals Announces 71 Pegylated 71 First Patient Dosed 71 Potent Antiviral Activity 71 Pharmacokinetics PK 71 Tyrosine Kinase Inhibitor 71 Predict Risk 71 Blood Clots 71 Teva Provides Update 71 Patent Covering 71 Naive Patients 71 Diuretic 71 Lanthanum Carbonate 71 Initiates Clinical Trial 71 Hormone Therapy 71 JAK2 Inhibitor 71 Combination REOLYSIN R 70 Plaque Psoriasis 70 Dose Response 70 Phase III Pivotal Trial 70 See CLINICAL PHARMACOLOGY 70 Bevacizumab 70 Randomized Study 70 Placebo Controlled Study 70 Menopausal Women 70 Metastatic Pancreatic Cancer 70 Nicotine Vaccine 70 Clinical Study Shows 70 Novel Method 70 Gene Variants 70 Dosed 70 Carboplatin Paclitaxel 70 Mesalamine 70 Therapeutic Efficacy 70 Increases Risk 70 Capecitabine 70 Skeletal Muscle 70 Drug Eluting 70 Prostate Cancer Vaccine 70 Cognitive Decline 70 Recurrent Breast Cancer 70 Contrast Agents 70 Androgen Receptor 70 Aliskiren 70 Mg Uk 70 Adalimumab 70 Glufosfamide 70 Chronic Constipation 70 Relapsed Refractory Multiple Myeloma 70 Atypical Antipsychotic 70 Long Term Survival 70 Chemotherapy Regimen 70 Vaginal Gel 70 Successfully Treated 70 Initiates Phase II 70 Dasatinib 70 Randomized Controlled Trials 70 Genes Linked 70 Bosutinib 70 Phase III Clinical Trials 70 Taxane 70 Commonly Used 70 Anti TNF 70 Lupus Drug 70 Methylnaltrexone 70 Initiates Clinical 70 Glatiramer Acetate 70 Hepatitis B Vaccine 70 Sulfonylurea 70 Expanded Indication 70 Blood Thinner 70 Stent Restenosis 70 Enzyme Replacement Therapy 70 Receives Approvable Letter 70 Carotid Stenting 70 TNF Tumor Necrosis Factor 70 Glucose Control 70 Serious Infections 70 Paraplatin ® 70 Migraine Headaches 70 Unstable Angina 70 Fluticasone 70 Prognostic Significance 70 Orthostatic Hypotension 70 Darbepoetin Alfa 70 Nymox NX 70 Regimens 70 Induction Therapy 70 Breast Cancer Treatment 70 FDA Accepts 70 Pafuramidine 70 Gastric Ulcers 70 Shows Promise 70 Neoadjuvant 70 Blocked Arteries 70 Fast Track Status 70 Clinical Trial Data 70 dasatinib Sprycel ® 70 Breast Tumors 70 Vaccine Adjuvant 70 Drug Resistant 70 Less Invasive 70 Desvenlafaxine Succinate 70 Pegylated Liposomal Doxorubicin 70 Invasive Breast Cancer 70 Acute Migraine 70 Achieves Primary Endpoint 70 TO AVOID PREGNANCY WHILE 70 Vitro Activity 70 Mg Usa 70 Initiate Phase III 70 Multicenter Trial 70 Proven Effective 70 Shows Promise Against 70 Decitabine 70 Acute Pancreatitis 70 Cardiogenic Shock 70 Boosts Survival 70 Sustained Release 70 Allogeneic 70 Hemolysis 70 Randomized Phase II 70 Protease Inhibitors 70 leukopenia pancytopenia thrombocytopenia 70 Ovarian Cancer Patients 70 Rectal Cancer 70 Anticancer Drugs 69 Lung Cancers 69 Hepatic Encephalopathy 69 ST Elevation Myocardial 69 Advanced Solid Tumors 69 HCV Genotype 69 Immunosuppression 69 First Patient Enrolled 69 Subcutaneous 69 Develop Novel 69 Shingles Vaccine 69 Cardiovascular Outcomes 69 Primary Hypercholesterolemia 69 Pegloticase 69 Antiangiogenic 69 Poorly Controlled 69 Nitazoxanide 69 Confirmatory Phase 69 Attenuates 69 Hepatitis C Virus 69 SPRYCEL ® 69 Impairs 69 Efficacy Trial 69 Bivalirudin 69 Treating Heart Failure 69 Lung Cancer Survival 69 Significant Reduction 69 Presents Preclinical 69 Sirolimus Eluting 69 Colorectal Adenomas 69 Voreloxin 69 Intracerebral Hemorrhage 69 Bone Metastases 69 Minimally Invasive Treatment 69 Small Molecule 69 Aurora Kinase 69 Gene Linked 69 Malignant Melanoma 69 alfa 2a 69 Epilepsy Drugs 69 RNAi Therapeutic 69 Anti Inflammatory Drug 69 Oral Formulation 69 Panic Disorder 69 Significant Efficacy 69 Testosterone Gel 69 Tumor Necrosis Factor 69 Prolonged Survival 69 Adefovir 69 Insulin Resistance 69 PEGylated anti 69 Demonstrate Significant 69 Potent Anti 69 Irinotecan 69 Cell Transplants 69 Effective Treatments 69 Genes Associated 69 IND Filing 69 Dialysis Patients 69 FDA APPROVES 69 Angiogenic 69 Vildagliptin 69 Prostate Biopsy 69 Pioglitazone 69 Novel Inhibitor 69 Severe Acne 69 R lenalidomide 69 Melphalan 69 Bone Mineral Density 69 Prostate Cancer Treatment 69 Successfully Completes Phase 69 Oral Anticoagulant 69 Cholesterol Drug 69 Patients Enrolled 69 Reduces Pain 69 Lowers Risk 69 Inhaled Insulin 69 Pemetrexed 69 Myelodysplastic Syndrome MDS 69 Data Suggest 69 Lipid Levels 69 Albuferon TM 69 Investigational Oral 69 Novel Anti Inflammatory 69 Virus Infection 69 Preterm Infants 69 sunitinib Sutent ® 69 Diffuse Large B 69 MEK Inhibitor 69 Enlarged Prostate 69 Poster Presentations 69 Elevated Levels 69 Weight Loss Drug 69 Drug Fails 69 Emerging Therapies 69 Safety Tolerability 69 Potent Inhibitor 69 Lenalidomide 69 Slows Progression 69 Cholesterol Levels 69 Antidepressant Drug 69 Levels Linked 69 Complete Remission 69 Artery Disease 69 Etanercept 69 Anti Inflammatory 69 Combination Clinical Trial 69 Lupus Nephritis 69 Aripiprazole 69 Antiviral Drugs 69 Valsartan 69 Trodusquemine MSI 69 Sipuleucel T 69 Ranolazine 69 Phase III Pivotal 69 Maribavir 69 Tipranavir 69 Safinamide 69 Antitumor 69 Pivotal Clinical Trial 69 Allergic Rhinitis 69 Erectile Dysfunction Drug 69 Kidney Transplants 69 Fulvestrant 69 Myocardial Ischemia 69 Blood Pressure Lowering 69 Showed Significant 69 Chronic Bronchitis 69 Positive Opinion 69 Bipolar Mania 69 Oral Mucositis 69 Brain Cells 69 Reduced Risk 69 Antigen Specific 69 Long Term Outcomes 69 Bosentan 69 Reduced Incidence 69 Inhalation Solution 69 Immune Cells 69 Posaconazole 69 Migraine Pain 69 Initiates Enrollment 69 Epidermal Growth Factor Receptor 68 Mouse Models 68 Capsules CII 68 Budesonide 68 Viral Load 68 Stem Cell Treatment 68 Eszopiclone 68 First Patient Treated 68 Glycemic Control 68 ISTODAX ® 68 Phase IIa Trial 68 Symptom Relief 68 Targeted Therapy 68 Chemotherapeutic Agents 68 Eculizumab 68 Thromboembolism 68 Randomized Placebo Controlled Trial 68 Receives FDA Clearance 68 Diabetic Foot Ulcer 68 Adverse Effects 68 Treat Heart Failure 68 Generic Versions 68 NICE Recommends 68 Gemcitabine 68 Tacrolimus 68 PKC# 68 Osteoarthritis Patients 68 Blind Placebo Controlled Trial 68 Severe Asthma 68 Extended Release Formulation 68 Stem Cell Transplants 68 Efficacy Results 68 Drug Prevents 68 Generalized Anxiety Disorder 68 Acute Coronary Syndromes 68 Inhalation Aerosol 68 Metabolic Efficiency 68 Brain Atrophy 68 CYP#A# CYP#D# 68 Gastric Cancer 68 Intravenous Formulation 68 Beta Blockers 68 Sirolimus Eluting Stent 68 Asthma Treatment 68 Adenoma 68 Severe Psoriasis 68 Fluconazole 68 Circulating Tumor Cells 68 R Saizen R 68 Brain Tumors 68 Paclitaxel Carboplatin 68 developing Bicifadine serotonin 68 Cell Lymphoma 68 Metabolic Disorder 68 Collaborators Present 68 Peginterferon Alfa 2b 68 Psoriasis Patients 68 Clinical Study 68 Desloratadine 68 Intracranial Aneurysms 68 brand ciclesonide HFA 68 Atopic Dermatitis 68 Secondary Hyperparathyroidism 68 Trastuzumab 68 Lamotrigine 68 Randomized Trials 68 Restenosis 68 Atypical Hemolytic Uremic Syndrome 68 Pralatrexate 68 Acute Myocardial Infarction 68 Oral Cladribine 68 Initiates Clinical Trials 68 Bladder Cancer 68 Immunogenicity 68 Monoclonal Antibody 68 Polymerase Inhibitor 68 Aflibercept 68 Selective Inhibitor 68 Factor Receptor 68 Cancer Recurrence 68 Sevelamer 68 Antipsychotic Medications 68 FDA Clearance 68 Lung Function 68 Liver Tumors 68 Randomized Clinical Trials 68 Receives Milestone Payment 68 Telaprevir VX 68 Ropinirole 68 C Reactive Protein 68 Parathyroid Hormone 68 Romidepsin 68 Testosterone Patch 68 Renal Tumors 68 Study Indicates 68 Files Investigational 68 Anticancer Compound 68 ritonavir boosted 68 Kidney Failure 68 Breast Cancer Cells 68 Reduce Mortality 68 Liver Damage 68 ORENCIA ® 68 Myelofibrosis 68 Drug Coated Stents 68 Aggressive Prostate Cancer 68 Tumor Targeting 68 Levoleucovorin 68 Treatment Regimens 68 Psoriasis Drug 68 Hemoglobin Levels 68 oral prodrug 68 Placebo Controlled 68 Heartburn Drugs 68 Mycophenolate Mofetil 68 Earns Milestone Payment 68 Chronic Lymphocytic Leukemia 68 Telithromycin 68 Cyclooxygenase 2 68 Septic Shock 68 Systemic Delivery 68 Uric Acid 68 Eltrombopag 68 RNAi Therapeutics 68 Migraine Treatment 68 sertraline Zoloft 68 Prophylaxis 68 Hematological Cancers 68 Synthetic Peptide 68 Contrast Agent 68 Percutaneous Tibial Nerve Stimulation 68 Drug Coated Stent 68 Cognitive Function 68 Thrombotic 68 Late Breaker 68 Aortic Stenosis 68 Double Blind Randomized 68 Receives Orphan Drug 68 Inflammatory Arthritis 68 Topline Results 68 Skin Lesions 68 Gum Disease 68 Antifungal 68 Preclinical Models 68 Oral Contraceptive 68 ORLive Presents 68 Novel Therapeutic 68 Blood Vessels 68 Montelukast 68 Elagolix 68 Inhaled Nitric Oxide 68 Natalizumab 68 Non Inferiority 68 Sangamo BioSciences Announces 68 Smallpox Vaccine 68 Immunomodulatory 68 Anticoagulant 67 Known hypersensitivity 67 Epileptic Seizures 67 Acute Attacks 67 Tumor Progression 67 Lower Blood Pressure 67 Begins Dosing 67 Signaling Pathway 67 Zorbtive TM 67 Significant Improvement 67 Commence Phase 67 B Cell Malignancies 67 Interferon beta 1a 67 Receives Positive Opinion 67 Antithrombin 67 Rheumatoid Arthritis Drug 67 Hematological Malignancies 67 Vicriviroc 67 Endothelial Cells 67 dependent kinase inhibitor 67 Dapagliflozin 67 C1 Inhibitor 67 Low Doses 67 FDA Approves Drug 67 Transdermal Delivery 67 Randomized Controlled 67 Chronic Renal Failure 67 HER2 Positive 67 Genetic Mutations 67 Obesity Linked 67 Non Invasive 67 Organ Rejection 67 Bone Marrow Cells 67 Abciximab 67 Granulocyte Colony Stimulating Factor 67 Tolvaptan 67 Allergic Reactions 67 erlotinib Tarceva ® 67 mGluR5 NAM 67 Short Stature 67 Eluting Stent 67 Abdominal Pain 67 Malaria Vaccine 67 NMDA Receptor 67 Inflammatory Markers 67 Sustained Virologic Response 67 Nasal Spray 67 Immunotherapeutic 67 Zoloft sertraline 67 FASLODEX 67 Nerve Pain 67 Erlotinib 67 Liposomal 67 Clopidogrel 67 Novel Treatments 67 Commercially Available 67 Urinary Incontinence 67 Cardiotoxicity 67 J Am Coll 67 Pregnancy Linked 67 thalidomide Thalomid 67 Denufosol 67 Diabetic Foot Ulcers 67 Study Proves 67 Anticancer Drug 67 Test Detects 67 Genes Predict 67 Oral Calcitonin 67 Cholesterol Lowering 67 Chronic Insomnia 67 Itraconazole 67 Newly Diagnosed Patients 67 Kinase Inhibitors 67 Oral Contraceptives 67 Hip Fractures 67 Left Ventricular Hypertrophy 67 mGluR5 negative 67 Moxifloxacin 67 Novel Compounds 67 Corticosteroid 67 Statin Drugs 67 Pegylated Interferon 67 pan HDAC inhibitor 67 Cognitive Deficits 67 Cardiovascular Mortality 67 Vaccine Candidate 67 Life Threatening 67 Tablet Formulation 67 Prevent Stroke 67 Cancer Treatments 67 Abdominal Fat 67 Tigecycline 67 Lowers Blood Pressure 67 induce orthostatic hypotension 67 Hepatocellular Carcinoma 67 Confirms Efficacy 67 Ischemic 67 Treatment Shows Promise 67 Proton Pump Inhibitors 67 Post Operative 67 LENALIDOMIDE 67 FDA Warns 67 Gout Patients 67 sapropterin dihydrochloride 67 Bone Fracture 67 Bisphosphonate 67 Carcinomas 67 Stomach Cancer 67 Genetic Disorder 67 Follicular Lymphoma 67 Recurrent Ovarian Cancer 67 R roscovitine CDK cyclin 67 Myelodysplastic Syndrome 67 topical gel formulation 67 Mitoxantrone 67 Preterm Delivery 67 Spinal Fractures 67 Cardiac Function 67 Pre Cancerous 67 Demonstrates Sustained 67 cetuximab Erbitux R 67 5 Fluorouracil 67 INTEGRILIN R 67 Antipsychotic Drug 67 Calcium Supplements 67 Cardiovascular Disease Risk 67 Malignant Glioma 67 Regenerative Cells 67 Treat Anemia 67 Intravesical 67 CYPHER R Sirolimus Eluting 67 Protein Linked 67 Antiviral Therapy 67 Targeted Therapies 67 Personalized Immunotherapy 67 EntreMed Presents 67 Antibiotic Treatment 67 Antidepressants Linked 67 Catheter Ablation 67 Infliximab 67 Pulmonary Artery 67 ergot derivatives 67 Left Ventricular 67 Often Misdiagnosed 67 ANDA Filing 67 Romiplostim 67 Antiplatelet 67 Renal Artery 67 Anticancer Agent 67 Detect Cancer 67 administered concomitantly 67 Allergic Asthma 67 Vitamin D Linked 67 Initiates Dosing 67 Salmeterol 67 Statistical Significance 67 Treatable 67 Deep Venous Thrombosis 67 Immune Mediated 67 Risedronate 67 Smooth Muscle 66 Oral Insulin 66 Adjunctive 66 Bare Metal Stent 66 Preclinical Efficacy 66 Adenoviral 66 Calcitonin 66 Sandostatin R 66 Enrolls First 66 Menopausal Symptoms 66 Reports Preclinical Data 66 Pharmacokinetic 66 Immune Cell 66 Severe Chronic Pain 66 Respiratory Syncytial Virus 66 Autoimmune Disease 66 Leukemias 66 Tocilizumab 66 Anemia Drug 66 Prove Effective 66 Gemzar ® 66 Physical Function 66 Bazedoxifene 66 Predict Response 66 Multicenter Randomized Double 66 Chronic Cough 66 Azacitidine 66 Bipolar Depression 66 oral dual endothelin 66 Shows Statistically Significant 66 Invasive Fungal Infections 66 Telbivudine 66 Reduces Mortality 66 Brain Scans 66 Trial Halted 66 Cytarabine 66 Prolongs Life 66 Electrical Stimulation 66 Chemotherapy Improves 66 Balloon Angioplasty 66 Cervical Cancer Vaccine 66 Chronic Heart Failure 66 Clostridium difficile Infection 66 Genetic Tests 66 Phase Ib Clinical Trial 66 Kidney Stones 66 Shown Effective 66 Cardiac Resynchronization 66 Thyroid Hormone 66 Ambrisentan 66 Hepatitis C Infection 66 Iron Deficiency 66 Persistent Asthma 66 Proton Pump Inhibitor 66 Palonosetron 66 Multicenter Study 66 Systematic Review 66 Maleate 66 vapreotide acetate 66 Tumor Response 66 Ziprasidone 66 Phase 2a Study 66 Copegus ® 66 Estrogen Receptor 66 Oral Spray 66 Delayed Release 66 Angioedema 66 Microalbuminuria

Back to home page